Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100™ (platelet function analyzer)

Investigative Radiology

Volumn 36, Issue 5, 2001, Pages 276-282

  De Tassigny, Alexandra D'Anglemont ^a   Idée, Jean Marc ^a   Corot, Claire ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Iodinated contrast media; Iodixanol; Iohexol; Ioxaglate; Meglumine; PFA 100 ; Platelet aggregation

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOXAGLIC ACID;

ANALYZER; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0342526197     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200105000-00005     Document Type: Article

References (29)

1. Idée JM, Corot C. Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: Pathophysiology and clinical aspects. Fund Clin Pharmacol 1999;13:613-633.
2. Chronos N. Implications of contrast media selection in interventional cardiology. In: Topol EJ, Serruys PW, eds. Current review of interventional cardiology. Philadelphia, PA: Current Medicine; 1995:279-293.
3. Eloy R, Corot C, Belleville J. Contrast media for angiography: Physicochemical properties, pharmacokinetics and biocompatibility. Clin Materials 1991;7:89-197.
4. Hirshfeld JW. Radiographic contrast agents. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, Braunwald E, eds. Cardiac imaging. Philadelphia, PA: W. B. Saunders; 1991:162-181.
5. Corot C, Chronos N, Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagulation Fibrinol 1996;7:602-608.
6. Chronos NAF, Goodall AH, Wilson DJ, et al. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993;88:2035-2044.
7. Heptinstall S, White A, Edwards N, et al. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: Implications for clinical practice ? Br J Haematol 1998;103: 1023-1030.
8. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer: PFA-100™. Semin Thromb Hemost 1995;21(suppl 2):106-112.
9. Dalby MCD, Dewar A, Davidson SJ, et al. Evaluation of angiographic contrast media and platelet function with impedance aggregometry and the PFA-100™ 'platelet function analyser.' Platelets 1999;10: 293-297.
10. Freed MS, O'Neill WW. Dissection and acute closure. In: Freed MS, Grines CL, eds. Manual of interventional cardiology. Birmingham, MI: Physician's Press; 1992:204-220.
11. Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372-379.
12. Li X, Gabriel DA. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad Radiol 1997;4:108-114.
13. Waller BF. Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease. Hum Pathol 1987;18:476-484.
14. Cucherat M, Leizorovicz A. Effects of non-ionic contrast media on abrupt vessel closure and ischaemic complications after angioplasty: A meta-analysis. Am J Cardiol 1999;84(suppl):98P. Abstract.
15. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol (Lond) 1962;67:67P-68P.
16. Berkowitz SD, Frelinger AL III, Hillman RS. Progress in point-of-care laboratory testing for assessing platelet function. Am Heart J 1998; 136(suppl):S51-S65.
17. Hézard N, Metz D, Nazeyrollas P, et al. Use of the PFA-100™ apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents. Thromb Haemost 2000;83:540-544.
18. Kundu SK, Heilmann EJ, Sio R, et al. Characterization of an in vitro platelet function analyzer, PFA-100™. Clin Appl Thromb Hemost 1996;2:241-249.
19. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases. Blood 1998;91:1325-1331.
20. Mammen EF, Comp PC, Gosselin R, et al. PFA-100™ system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
21. Ferguson JJ, Quinn M, Moake JL. Platelet physiology. In: Ferguson JJ, Chronos NAF, Harrington RA, eds. Antiplatelet therapy in clinical practice. London, UK: Martin Dunitz; 2000:15-34.
22. Gachet C, Hechler B, Leon C, et al. Activation of ADP receptors and platelet function. Thromb Haemost 1997;78:271-275.
23. Kunauli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J 1998;336:513-523.
24. Takahashi O. Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis. Food Chem Toxicol 2000;38:203-218.
25. Manikeri SR, Raghu CN, Dadkar VN, et al. Species variation in platelet function and blood coagulation. Ind J Med Res 1980;71: 446-450.
26. Bernat A, Hoffmann P, Savi P, et al. Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GPIIb/IIIa antagonist. J Cardiovasc Pharmacol 1999;33:897-904.
27. Leadley RJ Jr, Chi L, Rebello SS, et al. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods 2000;43:101-116.
28. Heptinstall S, Patterson C, Snaderson H, et al. Meglumine, a component of preparations of the radiographic contrast medium ioxaglate, inhibits platelet aggregation. Haemostasis 2000;30:57. Abstract.
29. Parvez Z, Moncada R, Fareed J, et al. Antiplatelet action of intravascular contrast in diagnostic procedures. Invest Radiol 1984;19: 208-211.